相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
Milim Kim et al.
BREAST CANCER RESEARCH (2020)
Prognostic role of immune infiltrates in breast ductal carcinoma in situ
Xiao-Yang Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
Nathan Reynders et al.
CELLS (2019)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci et al.
SEMINARS IN CANCER BIOLOGY (2018)
CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
Chenlu Zhang et al.
BMC CANCER (2018)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
Nathan Karin et al.
CYTOKINE (2018)
CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis (Expression of Concern of Vol 124, Pg 2009, 2014)
Yaniv Zohar et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status
Yul Ri Chung et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
Chang Xian Li et al.
JOURNAL OF HEPATOLOGY (2016)
EMT in Breast Carcinoma-A Review
Joema Felipe Lima et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis
Ahmed A. Ejaeidi et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Natural and therapy-induced immunosurveillance in breast cancer
Guido Kroemer et al.
NATURE MEDICINE (2015)
IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
Serena Lunardi et al.
ONCOIMMUNOLOGY (2015)
C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients
Erik Hilborn et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Heparanase enhances myeloma progression via CXCL10 downregulation
U. Barash et al.
LEUKEMIA (2014)
Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry
Anna Marie Mulligan et al.
CLINICAL CANCER RESEARCH (2013)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
The emerging role of CXCL10 in cancer (Review)
Mingli Liu et al.
ONCOLOGY LETTERS (2011)
Epithelial-mesenchymal transition in development and cancer
Douglas S. Micalizzi et al.
FUTURE ONCOLOGY (2009)
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
Xinrong Ma et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
Adi Zipin-Roitman et al.
CANCER RESEARCH (2007)
Targeted in vivo expression of IFN-γ-inducible protein 10 induces specific antitumor activity
Xiuli Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: Relevance for the development of human breast cancer
Dipak Datta et al.
CANCER RESEARCH (2006)
The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines
L Goldberg-Bittman et al.
IMMUNOLOGY LETTERS (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
Chemokine receptors: Multifaceted therapeutic targets
AEI Proudfoot
NATURE REVIEWS IMMUNOLOGY (2002)
分享论文
